• University of Edinburgh
• Senior Clinical Research Fellow / Honorary Consultant Psychiatrist

Declaration on 9 June 2026

Declaration period: 2025

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £100 to under £1,000
• Details: Shionogi (paid to University of Edinburgh)

Declaration on 9 June 2026

Declaration period: 2025

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £100 to under £1,000
• Details: GexVal - paid to University of Edinburgh

Declaration on 9 June 2026

Declaration period: 2025

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £100 to under £1,000
• Details: Enthorin Therapeutics (paid to University of Edinburgh)

Declaration on 14 December 2023

Declaration period: 2011

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £1,000 to under £2,000
• Details: Roche (paid to University of Edinburgh)

Academic

• Relates to: Research grants
• Income band: £100,000+
• Details: Novartis - Clinical Trial grant paid to NHS Lothian for “A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate AFQ056 in Adult Patients With Fragile X Syndrome” plus the 2 year follow-up open label study; and “A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate AFQ056 in Adolescent Patients With Fragile X Syndrome” plus the 2 year follow-up open label study.

Declaration on 14 December 2023

Declaration period: 2012

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Academic

• Relates to: Research grants
• Income band: £50,000 to under £100,000
• Details: Roche - Clinical Trial Grant paid to NHS Lothian and University of Edinburgh for “A randomized, double-blind, 12- week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome”

Declaration on 14 December 2023

Declaration period: 2013

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £1,000 to under £2,000
• Details: Novartis (paid to University of Edinburgh)

Declaration on 14 December 2023

Declaration period: 2014

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £2,000 to under £5,000
• Details: Novartis (paid to University of Edinburgh)

Declaration on 14 December 2023

Declaration period: 2019

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £2,000 to under £5,000
• Details: Roche (paid to University of Edinburgh)

Academic

• Relates to: Research grants
• Income band: £10,000 to under £50,000
• Details: Roche - Clinical Trial Grant paid to NHS Lothian for "A Phase III, Randomised, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study Of Balovaptan In Adults With Autism Spectrum Disorder with a 2-year Open-Label Extension"

Declaration on 14 December 2023

Declaration period: 2023

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £100 to under £1,000
• Details: Shionogi (paid to University of Edinburgh)

Declaration on 11 December 2023

Declaration period: 2021

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £100 to under £1,000
• Details: Shionogi (paid to University of Edinburgh)

Declaration on 11 December 2023

Declaration period: 2022

Main employment

• Type: Academic
• Details: Senior Clinical Research Fellow / University of Edinburgh

Consultancy

• Relates to: Pharmaceutical companies
• Income band: £2,000 to under £5,000
• Details: Shionogi (paid to University of Edinburgh); Enthorin Therapeutics (paid to University of Edinburgh)

Academic

• Relates to: Research grants
• Income band: £10,000 to under £50,000
• Details: Zynerba Pharmaceuticals - Clinical Trial Grant for "A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome – RECONNECT"

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.